ABBV vs. MTD: A Head-to-Head Stock Comparison
UpdatedHere’s a clear look at ABBV and MTD, comparing key factors like performance, valuation metrics, dividends, and financial strength. It’s built for investors or anyone curious to see how these two stocks match up.
Company Overview
ABBV dominates in value with a market cap of 321.13 billion USD, eclipsing MTD’s 23.55 billion USD by roughly 13.63×.
MTD carries a higher beta at 1.40, indicating it’s more sensitive to market moves, while ABBV remains steadier at 0.55.
| Symbol | ABBV | MTD |
|---|---|---|
| Company Name | AbbVie Inc. | Mettler-Toledo International Inc. |
| Country | US | US |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Medical - Diagnostics & Research |
| CEO | Mr. Robert A. Michael CPA | Mr. Patrick K. Kaltenbach |
| Price | 181.8 USD | 1,133.26 USD |
| Market Cap | 321.13 billion USD | 23.55 billion USD |
| Beta | 0.55 | 1.40 |
| Exchange | NYSE | NYSE |
| IPO Date | January 2, 2013 | November 14, 1997 |
| ADR | No | No |
Performance Comparison
This chart compares the performance of ABBV and MTD over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).
Hover over the lines to see the investment’s value and total return (%) at specific dates.
Data is adjusted for dividends and splits.
Valuation Metrics Comparison
For a detailed comparison of valuation metrics between ABBV and MTD, please refer to the table below.
| Symbol | ABBV | MTD |
|---|---|---|
| Price-to-Earnings Ratio (P/E, TTM) | 76.62 | 27.85 |
| Forward PEG Ratio (TTM) | 7.16 | 2.71 |
| Price-to-Sales Ratio (P/S, TTM) | 5.60 | 6.15 |
| Price-to-Book Ratio (P/B, TTM) | 226.35 | 7.31 |
| Price-to-Free Cash Flow Ratio (P/FCF, TTM) | 20.87 | 27.10 |
| EV-to-EBITDA (TTM) | 23.58 | 21.22 |
| EV-to-Sales (TTM) | 6.73 | 6.67 |
| EV-to-Free Cash Flow (TTM) | 25.08 | 29.41 |
Dividend Comparison
ABBV delivers a 3.51% dividend yield, blending income with growth, whereas MTD appears to retain its profits, possibly to fund operations, R&D, or other growth initiatives.
| Symbol | ABBV | MTD |
|---|---|---|
| Dividend Yield (TTM) | 3.51% | 0.00% |
Financial Strength Metrics Comparison
This section dives into the financial resilience of ABBV and MTD, spotlighting key metrics like liquidity, leverage, and debt coverage. Check out the standout observations below where notable differences or extremes pop up.
- ABBV’s current ratio of 0.76 signals a possible liquidity squeeze, while MTD at 1.01 comfortably covers its short-term obligations.
- Both ABBV (quick ratio 0.64) and MTD (quick ratio 0.70) fall below 0.8, meaning their most liquid assets—excluding inventory—aren’t enough to meet short-term obligations. This could force them to rely on receivables, inventory turn, or external financing.
- ABBV is heavily leveraged (debt-to-equity ratio 49.22), which can boost returns but raises risk if borrowing costs climb, while MTD at 0.64 keeps leverage at a more moderate level.
| Symbol | ABBV | MTD |
|---|---|---|
| Current Ratio (TTM) | 0.76 | 1.01 |
| Quick Ratio (TTM) | 0.64 | 0.70 |
| Debt-to-Equity Ratio (TTM) | 49.22 | 0.64 |
| Debt-to-Assets Ratio (TTM) | 0.51 | 0.64 |
| Interest Coverage Ratio (TTM) | 6.14 | 16.23 |